Drug intelligence / Profile preview

Shiling Oil

Development stage: Unknown
Modality: Small Molecules
Administration: Topical

Overview

Shiling Oil is a traditional topical external analgesic originating from Hong Kong, formulated as a multi-ingredient herbal medicated oil. It contains a concentrated blend of menthol crystal (33%), methyl salicylate (30%), eucalyptus oil (28%), camphor (5%), lavender oil (2%), and dill oil (2%). The product acts as a counterirritant and local analgesic, providing temporary relief for minor aches and pains associated with muscles and joints, including headaches, arthritis, strains, and sprains. Originally developed in 1923, it is marketed as an over-the-counter (OTC) traditional medicine and is registered in Hong Kong.

Brand names: Shiling OilShiling Oil External Analgesic

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)COX

Beyond the preview

Go deeper on Shiling Oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shiling Oil.

Explore the full profile